| Current Price | $18.92 | Mkt Cap | $1.4B |
|---|---|---|---|
| Open | $18.69 | P/E Ratio | 0.00 |
| Prev. Close | $18.68 | Div. (Yield) | $0.00 (0.0%) |
| Daily Range | $18.56 - $19.68 | Volume | 941,748 |
| 52-Wk Range | $11.70 - $22.82 | Avg. Daily Vol. | 924,110 |
| Current Price | $18.92 | Mkt Cap | $1.4B |
|---|---|---|---|
| Open | $18.69 | P/E Ratio | 0.00 |
| Prev. Close | $18.68 | Div. (Yield) | $0.00 (0.0%) |
| Daily Range | $18.56 - $19.68 | Volume | 941,748 |
| 52-Wk Range | $11.70 - $22.82 | Avg. Daily Vol. | 924,110 |
The best Bull and Bear pitches based on recency and number of recommendations.
Read the most recent pitches from players about FATE.
Recs
shanelofgren
(< 20)
Submitted: 9/25/2018 10:15:15 AM :
Start Price:
$9.49
NASDAQ:FATE Score:
+78.09
Bet on iPSC derived T cells for adoptive cell therapy.
Recs
NoPlaceLikeHome
(42.75)
Submitted: 3/9/2017 10:28:18 AM :
Start Price:
$4.09
NASDAQ:FATE Score:
+329.38
With a phase 3 trial that can support an FDA application for approval of Zilretta, a non-opioid therapy for knee pain in osteoarthritis patients, under their belt, they are on the road to final approval. Long story short, if it gets the FDA green light, 10% market penetration is over $1B in revenue. It is non-opiod which means prescribers and patients do not have to hassle with increased scrutiny writing and filling scripts and I believe that will make market penetration very easy. At under $200 million in market cap and a $1B+ opportunity, I can't pass up the risk/reward. Buy!!
Recs
oscillation
(73.26)
Submitted: 2/11/2016 1:26:54 PM :
Start Price:
$1.72
NASDAQ:FATE Score:
+929.70
nev
Find the members with the highest scoring picks in FATE.
stainsolution (< 20) Score: +1,044.66
The Score Leader is the player with the highest score across all their picks in FATE.
|
Top Pick |
Member Name |
Member Rating |
Start Date |
Call |
Time Frame |
Start Price |
Stock Gain |
Index Gain |
Score | Commentary |
|---|---|---|---|---|---|---|---|---|---|---|
| stainsolution | < 20 | 2/17/2016 |
|
5Y | $1.57 | +1,108.95% | +64.29% | +1,044.66 | 0 Comment | |
| oscillation | 73.26 | 2/11/2016 |
|
5Y | $1.72 | +1,003.21% | +73.51% | +929.70 | 1 Comment | |
|
biznessdoc | 63.06 | 8/15/2016 |
|
5Y | $2.57 | +636.19% | +44.75% | +591.43 | 0 Comment |
| portefeuille2 | 99.10 | 8/17/2016 |
|
5Y | $2.65 | +613.96% | +45.34% | +568.62 | 0 Comment | |
| shonny2 | < 20 | 2/6/2017 |
|
5Y | $2.87 | +559.23% | +38.44% | +520.79 | 0 Comment | |
| NoPlaceLikeHome | 42.75 | 3/9/2017 |
|
5Y | $4.09 | +363.16% | +33.77% | +329.38 | 3 Comments | |
| Under5 | < 20 | 11/16/2017 |
|
5Y | $4.40 | +329.99% | +22.46% | +307.53 | 0 Comment | |
|
|
TruffelPig | < 20 | 3/1/2017 |
|
5Y | $4.40 | +330.00% | +32.91% | +297.09 | 0 Comment |
| skellsmother | < 20 | 11/11/2013 |
|
1Y | $4.45 | +325.17% | +78.71% | +246.46 | 1 Comment | |
| cyberterrorist | < 20 | 11/12/2013 |
|
1Y | $4.51 | +319.51% | +79.07% | +240.44 | 1 Comment |
See what the Wall Street professionals think, according to their public statements and filings.
